The Neuroimmune Pharmacology of SARS-CoV-2

Authors

Santosh Kumar, University of Tennessee Health Science Center
Sowmya Yelamanchili, College of Medicine
Pankaj Seth, National Brain Research Center
Jean M. Bidlack, University of Rochester School of Medicine and Dentistry
Gurudutt Pendyala, College of Medicine
Sanjay Maggirwar, The George Washington University School of Medicine and Health Sciences
Sulie L. Chang, Seton Hall University

Abstract

This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021. Graphical abstract: Top row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.[Figure not available: see fulltext.].

Publication Title

Journal of Neuroimmune Pharmacology

Recommended Citation

Kumar, S., Yelamanchili, S., Seth, P., Bidlack, J., Pendyala, G., Maggirwar, S., & Chang, S. (2021). The Neuroimmune Pharmacology of SARS-CoV-2. Journal of Neuroimmune Pharmacology, 16 (4), 699-705. https://doi.org/10.1007/s11481-021-10038-z